Ibuprofen Active Pharmaceutical Ingredient (Api) Market Size to grow by USD 26.3 million between 2024-2028
The Ibuprofen Active Pharmaceutical Ingredient (Api) Market is segmented by End-user (Pharmaceutical companies and Contract manufacturing organizations), Product (Prescription and Over-the-counter), and Geography (Asia, North America, Europe, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 26.3 million, at a CAGR of 2.08% during the forecast period. There are several companies that are contributing to the market as per this report. Paradigm shift in API manufacturing .
By End-user, the Pharmaceutical companies segment is projected to dominate the market size in 2024
Ibuprofen Active Pharmaceutical Ingredient (API) is a crucial component in over-the-counter and prescription medications, renowned for its potent analgesic and anti-inflammatory properties. The global Ibuprofen API market is witnessing significant growth, driven by increasing demand for pain relief and inflammation management products. Key players in this market focus on enhancing production capacity and improving product quality to cater to the burgeoning consumer base. Regulatory compliance and cost-effective manufacturing are critical challenges for market participants.
For insights on company offerings- Request a sample report!
By Product, Prescription segment is expected to hold the largest market size for the year 2024
Ibuprofen Active Pharmaceutical Ingredient (API) is a crucial component in over-the-counter and prescription medications, renowned for its potent analgesic and anti-inflammatory properties. The Ibuprofen API market witnesses significant growth due to increasing demand for pain relief and inflammation management drugs. Key players in this market focus on enhancing production capacity and improving product quality to cater to the surging market needs. The market's expansion is further fueled by rising healthcare expenditures, an aging population, and a growing preference for self-medication.
Why is Asia forecasted to hold the largest regional market size in 2024?
The Ibuprofen Active Pharmaceutical Ingredient (API) market signifies a significant business sector, characterized by robust growth and substantial demand. Ibuprofen APIs are essential components in over-the-counter and prescription medications, catering to pain relief and inflammation management. Market expansion is driven by increasing consumer awareness and preference for effective pain management solutions, coupled with technological advancements in API manufacturing processes. Businesses operating in this sector aim to capitalize on these trends, ensuring regulatory compliance and maintaining high-quality standards to meet evolving market demands.
To access the valuable insights - Download the Free Sample Report
Research Analysis Overview
Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is a widely used Active Pharmaceutical Ingredient (API) for treating various medical conditions, including menstrual discomfort associated with dysmenorrhea. The World Health Organization (WHO) has recognized ibuprofen's importance in healthcare, making it an essential medicine. The production of ibuprofen involves advanced techniques such as combinatorial chemistry, high-throughput methods, and bioinformatics. Top pharmaceutical manufacturers produce ibuprofen in the form of syrups, capsules, and tablets. However, the production process comes with challenges, including high manufacturing costs and environmental drawbacks. The synthetic route of ibuprofen involves several steps, which can lead to kidney damage and gastrointestinal bleeding as side effects. Biopharmaceutical companies are exploring new synthetic routes to minimize these risks. Moreover, ibuprofen is effective in treating chronic diseases such as migraine, rheumatoid arthritis, and other inflammatory conditions. The pharmaceutical industry's metamorphosis has led to the emergence of new players, particularly in emerging economies, increasing competition and driving down costs. Geriatric patients, who are more susceptible to side effects, require special considerations in the production and use of ibuprofen.
Market Research Overview
In the expansive landscape of the global pharmaceuticals market, encompassing entities involved in the research and development (R&D) or manufacturing of generic and non-generic drugs, as well as veterinary medicines, the market size is determined by Technavio via the consolidated revenue generated by providers of pharmaceuticals, biotechnology, life sciences tools and services, equipment, and supplies. Factors propelling the market's growth include the increasing aging population, with the number of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe projected to attain a similar demographic ratio by 2030. - The Ibuprofen Active Pharmaceutical Ingredient (Api) Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
